Cargando…

Tumor-Educated Platelets as a Promising Biomarker for Blood-Based Detection of Renal Cell Carcinoma

PURPOSE: Tumor-educated platelets (TEPs) are a promising liquid biopsy in many cancers. However, their role in renal cell carcinoma (RCC) is unknown. Thus, this study explored the diagnostic value of TEPs in RCC patients. METHODS: Platelets were prospectively collected from 24 RCC patients and 25 co...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xiao, Ruotao, Liu, Cheng, Zhang, Bo, Ma, Lulin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8936192/ https://www.ncbi.nlm.nih.gov/pubmed/35321426 http://dx.doi.org/10.3389/fonc.2022.844520

Ejemplares similares

Preoperative Platelet Distribution Width Represents a Novel Prognostic Biomarker in Patients With Nonmetastatic Renal Cell Carcinoma: A Retrospective Clinical Analysis
por: Xiao, Ruotao, et al.
Publicado: (2022)

Prognostic Factors and a Nomogram Predicting Overall Survival and Cancer-Specific Survival for Patients with Collecting Duct Renal Cell Carcinoma
por: Xiao, Ruotao, et al.
Publicado: (2021)

Development and validation of nomogram based on a novel platelet index score to predict prognosis in patients with renal cell carcinoma
por: Xiao, Ruotao, et al.
Publicado: (2021)

Small Nuclear RNAs (U1, U2, U5) in Tumor-Educated Platelets Are Downregulated and Act as Promising Biomarkers in Lung Cancer
por: Dong, Xiaohan, et al.
Publicado: (2020)

Preoperative anaemia and thrombocytosis predict adverse prognosis in non‐metastatic renal cell carcinoma with tumour thrombus
por: Xiao, Ruotao, et al.
Publicado: (2021)

Circulating Tumor Cells: A Promising Biomarker in the Management of Nasopharyngeal Carcinoma
por: Wu, Jiangtao, et al.
Publicado: (2021)

Preoperative stereotactic body radiotherapy combined with surgical treatment for renal cell carcinoma and inferior vena cava tumour thrombus: study protocol for a single-arm cohort trial
por: Liu, Yunchong, et al.
Publicado: (2022)

A Nomogram Predicting the Progression-Free Survival of Nonmetastatic Renal Cell Carcinoma Patients With Venous Thrombus After Surgery
por: Zhang, Yu, et al.
Publicado: (2022)

Liquid Biopsies in Renal Cell Carcinoma—Recent Advances and Promising New Technologies for the Early Detection of Metastatic Disease
por: Lakshminarayanan, Harini, et al.
Publicado: (2020)

Tumor-Educated Platelets Facilitate Thrombus Formation Through Migration
por: Liu, Zheming, et al.
Publicado: (2022)

Contents in tumor-educated platelets as the novel biosource for cancer diagnostics
por: Zhang, Qianru, et al.
Publicado: (2023)

Tumor-Educated Platelets: A Review of Current and Potential Applications in Solid Tumors
por: Varkey, Joyce, et al.
Publicado: (2021)

Tumor-Educated Platelet miR-18a-3p as a Novel Liquid-Biopsy Biomarker for Early Diagnosis and Chemotherapy Efficacy Monitoring in Nasopharyngeal Carcinoma
por: Sun, Kaiyu, et al.
Publicado: (2021)

The Significant Role of Tumor Volume on the Surgical Approach Choice, Surgical Complexity, and Postoperative Complications in Renal Cell Carcinoma With Venous Tumor Thrombus From a Large Chinese Center Experience
por: Baheen, Qais, et al.
Publicado: (2022)

Identification of CCL4 as an Immune-Related Prognostic Biomarker Associated With Tumor Proliferation and the Tumor Microenvironment in Clear Cell Renal Cell Carcinoma
por: Zhang, Lu, et al.
Publicado: (2021)

Investigating Urinary Circular RNA Biomarkers for Improved Detection of Renal Cell Carcinoma
por: Peter, Madonna R., et al.
Publicado: (2022)

RNA Sequencing of Tumor-Educated Platelets Reveals a Three-Gene Diagnostic Signature in Esophageal Squamous Cell Carcinoma
por: Liu, Tiejun, et al.
Publicado: (2022)

Tumor-derived extracellular vesicle nucleic acids as promising diagnostic biomarkers for prostate cancer
por: Diao, Yanjun, et al.
Publicado: (2023)

Blood-based biomarkers for immune-based therapy in advanced HCC: Promising but a long way to go
por: Sung, Pil Soo, et al.
Publicado: (2022)

Tumor Seeding With Renal Cell Carcinoma After Renal Biopsy
por: Andersen, M.F.B., et al.
Publicado: (2016)

CTHRC1 Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Kidney Renal Papillary Cell Carcinoma and Kidney Renal Clear Cell Carcinoma
por: Zhou, Fenfang, et al.
Publicado: (2021)

FGL1 as a Novel Mediator and Biomarker of Malignant Progression in Clear Cell Renal Cell Carcinoma
por: Lv, Zheng, et al.
Publicado: (2021)

Nicotinamide N-Methyltransferase: A Promising Biomarker and Target for Human Cancer Therapy
por: Li, Xiao-Yu, et al.
Publicado: (2022)

Circulating tumor cell associated white blood cell cluster as a biomarker for metastasis and recurrence in hepatocellular carcinoma
por: Chen, Jing, et al.
Publicado: (2022)

Systematic Analysis of microRNA Biomarkers for Diagnosis, Prognosis, and Therapy in Patients With Clear Cell Renal Cell Carcinoma
por: Cheng, Guiyun, et al.
Publicado: (2020)

Long non-coding RNAs as prognostic biomarkers in papillary renal cell carcinoma
por: Yang, Feilong, et al.
Publicado: (2019)

Clinical utility and diagnostic value of tumor-educated platelets in lung cancer: a systematic review and meta-analysis
por: Wiyarta, Elvan, et al.
Publicado: (2023)

AURKB: a promising biomarker in clear cell renal cell carcinoma
por: Wan, Bangbei, et al.
Publicado: (2019)

Molecular Characterization of the Tumor Microenvironment in Renal Medullary Carcinoma
por: Tourigny, David S., et al.
Publicado: (2022)

New Blood Biomarkers for the Diagnosis of AFP-Negative Hepatocellular Carcinoma
por: Wang, Ting, et al.
Publicado: (2020)

Peripheral Blood Genetic Biomarkers for the Early Diagnosis of Hepatocellular Carcinoma
por: Song, Ting, et al.
Publicado: (2021)

GFAPδ: A Promising Biomarker and Therapeutic Target in Glioblastoma
por: Radu, Roxana, et al.
Publicado: (2022)

Ferroptosis and tumor immunotherapy: A promising combination therapy for tumors
por: Cai, Huazhong, et al.
Publicado: (2023)

Application of Data Science in Circulating Tumor DNA Detection: A Promising Avenue Towards Liquid Biopsy
por: Li, Ming, et al.
Publicado: (2021)

Verteporfin Is a Promising Anti-Tumor Agent for Cervical Carcinoma by Targeting Endoplasmic Reticulum Stress Pathway
por: Wang, Meng, et al.
Publicado: (2020)

Integrative analysis of transcriptomic landscape and urinary signature reveals prognostic biomarkers for clear cell renal cell carcinoma
por: Zhang, Wei, et al.
Publicado: (2023)

Circulating Tumor Cells in Renal Cell Carcinoma: Recent Findings and Future Challenges
por: Santoni, Matteo, et al.
Publicado: (2019)

HCC biomarkers – state of the old and outlook to future promising biomarkers and their potential in everyday clinical practice
por: Schlosser, Sophie, et al.
Publicado: (2022)

Influence of Deep Invasive Tumor Thrombus on the Surgical Complexity and Prognosis of Patients With Non-Metastatic Renal Cell Carcinoma Combined With Venous Tumor Thrombus
por: Zhao, Xun, et al.
Publicado: (2022)

Robot-Assisted Laparoscopic IVC Treatment Strategy in Retroperitoneal Tumors
por: Liu, Lei, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_hsf7ktdi8u95609bjmcpv28q33